UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 20, 2024 4:00 P.M.
Form:
S-3
CIK:
0001623526
Company Name:
Stoke Therapeutics, Inc.
File Number:
333-280172